ghrelin glp-1 Figure 2 from Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB Ghrelin: Current Biology

Should someone stop GLP-1 treatment because of bloating

exendin-based glucagon like peptide-1 receptor agonists: a retrospective study in patients with type 2 diabetes

GLP-1 RAs (e.g., liraglutide) demonstrated significant cardiovascular benefit

Oxidative pathways in the sickle cell and beyond

Hes less interested in my achieving some ideal weight than taking the weight off my knees (and avoiding knee surgery)

This metabolic activity makes visceral fat a frequent measurement point in growth-hormone pathway research, since compounds studied for their effect on endogenous growth hormone release are often evaluated specifically against visceral fat mass rather than total body fat